The global non-invasive aesthetic treatment market size is projected to grow from USD 4.60 billion in 2021 to USD 9.45 billion by 2026 at a CAGR value of 13.1%. The increasing number of non-invasive aesthetic/cosmetic treatments performed each year, rising consumer awareness of non-invasive and painless cosmetic treatments, and the increasing availability of technologically advanced and sophisticated medical devices are the primary drivers supporting the growth of the non-invasive aesthetic treatment market. Read More »
The global end-stage renal disease market size is projected to grow from USD 74.01 billion in 2021 to USD 144.09 billion by 2026 at a CAGR value of 12.1%. The end-stage renal disease (ESRD) market is predicted to be driven by a spike in the number of kidney failure sufferers and the development of technologically improved medical devices and equipment such as minimal dialysis equipment and artificial kidneys. Read More »
The urinary incontinence market is estimated to be valued at USD 3.26 billion in 2021 and is projected to reach USD 4.67 billion by 2026 at a CAGR of 7.89%. The expansion of overall urinary incontinence market size is due to, an aging demographic with an elevated danger of urological illnesses, and an increment in urinary incontinent patient populations switching from mainstream treatment options to sophisticated surgical therapies. Read More »
The global ovarian cancer diagnostics market is projected to grow from USD 25.0 billion in 2021 to USD 36.5 billion by 2026 at a CAGR value of 7.5%. Factors like the rising prevalence of ovarian cancer, rising consumption of unhealthy foods, increasing chronic disorders related to the reproductive organ, technological advancements in cancer diagnosis, rising awareness regarding pre-disease diagnosis and other health concerns, non-invasive nature of the technique to detect the tumor will help the market grow rapidly from 2021 to 2026. Read More »
The global cardiac monitoring devices market is projected to grow from USD 22.1 billion in 2021 to USD 26.8 billion by 2026 at a CAGR value of 4.0%. Growing incidences of cardiovascular diseases and the growing demand for homecare among patients have been the major drivers of the cardiac monitoring market. Read More »
The global infectious disease therapeutics market is expected to grow from USD 48.77 billion in 2021 to USD 57.21 billion in 2026, at a CAGR of 7.12%. The market drivers which contribute to the infectious disease therapeutics market growth include rising infectious disease, an increasing number of surgeries, high prevalence of chronic diseases such as cardiovascular and cancer, rising cases of accidents, changing food habits, lack of proper sanitation measures taken by healthcare providers, and personal unhygienic conditions, lack of antibodies & immunity, and growing patient pool. Read More »
The global comprehensive metabolic panel testing market will grow from USD 11.5 billion in 2021, to USD 13.8 billion in 2026 with a CAGR value of 7.5%. Increasing prevalence of cardiovascular diseases and diabetes, the emergence of automated systems in laboratories, efficient and rapid results, development of data management solutions and introduction of innovative solutions for enhancing efficiency and minimizing errors are expected to increase demand for the comprehensive metabolic panel testing market. Read More »
The global point of care diagnostics market size is projected to grow from USD 29.5 billion in 2021 to USD 50.6 billion by 2026 at a CAGR value of 11.4%. Technological advancements in diagnostic medicine have been the major driver of the POC diagnostics market. Read More »
The global glucose analyzers market is expected to grow from USD 12.45 billion in 2021 to USD 18.05 billion in 2026 at a CAGR of 7.6% during the forecast period. The glucose analyzers market will grow rapidly mainly due to the rising demand for home-based glucose testing devices and the rising adoption of innovative technologies by hospitals and diagnostic laboratories. The Read More »
The global reusable autoinjectors market is projected to grow at a CAGR value of 11.7% during the forecast period [2021 to 2026]. Reusable autoinjectors are becoming increasingly popular among patients suffering from diseases that require multiple injection doses in a day. Read More »